Abstract

Celiac Disease (CD) is a gluten sensitive enteropathy that remains widely undiagnosed and implementation of massive screening tests is needed to reduce the long term complications associated to untreated CD. The main CD autoantigen, human tissue transglutaminase (TG2), is a challenge for the different expression systems available since its cross-linking activity affects cellular processes. Plant-based transient expression systems can be an alternative for the production of this protein. In this work, a transient expression system for the production of human TG2 in Nicotiana benthamiana leaves was optimized and reactivity of plant-produced TG2 in CD screening test was evaluated. First, a subcellular targeting strategy was tested. Cytosolic, secretory, endoplasmic reticulum (C-terminal SEKDEL fusion) and vacuolar (C-terminal KISIA fusion) TG2 versions were transiently expressed in leaves and recombinant protein yields were measured. ER-TG2 and vac-TG2 levels were 9- to 16-fold higher than their cytosolic and secretory counterparts. As second strategy, TG2 variants were co-expressed with a hydrophobic elastin-like polymer (ELP) construct encoding for 36 repeats of the pentapeptide VPGXG in which the guest residue X were V and F in ratio 8:1. Protein bodies (PB) were induced by the ELP, with a consequent two-fold-increase in accumulation of both ER-TG2 and vac-TG2. Subsequently, ER-TG2 and vac-TG2 were produced and purified using immobilized metal ion affinity chromatography. Plant purified ER-TG2 and vac-TG2 were recognized by three anti-TG2 monoclonal antibodies that bind different epitopes proving that plant-produced antigen has immunochemical characteristics similar to those of human TG2. Lastly, an ELISA was performed with sera of CD patients and healthy controls. Both vac-TG2 and ER-TG2 were positively recognized by IgA of CD patients while they were not recognized by serum from non-celiac controls. These results confirmed the usefulness of plant-produced TG2 to develop screening assays. In conclusion, the combination of subcellular sorting strategy with co-expression with a PB inducing construct was sufficient to increase TG2 protein yields. This type of approach could be extended to other problematic proteins, highlighting the advantages of plant based production platforms.

Highlights

  • Celiac disease is a chronic disorder caused by the ingestion of prolamins from wheat, barley, rye, or oats, which affects around 1% of the general population (Abadie et al, 2011)

  • No significant differences were observed between endoplasmic reticulum (ER)-tissue transglutaminase 2 (TG2) and vac-TG2, suggesting that fusion to either SEKDEL or KISIA C-terminal signals is efficient to increase TG2 accumulation levels

  • In this work we showed that TG2 fused to the C terminal KDEL or KISIA sorting signals accumulated at significantly higher levels than the cytosolic and apoplast versions, confirming the convenience of testing different subcellular compartments as strategy to increase accumulation levels

Read more

Summary

Introduction

Celiac disease is a chronic disorder caused by the ingestion of prolamins from wheat, barley, rye, or oats, which affects around 1% of the general population (Abadie et al, 2011). Low recombinant protein yields are generally obtained since TG 2 cross-linking activity has toxic effects on cell growth and development (Griffin et al, 2002). No transgenic BY-2 clones were obtained for the cytosolic TG2 construct probably due to toxic effect of this enzyme, which might prevent regeneration and growth of the transformed BY2 cells (Sorrentino et al, 2005). Apo-TG2 accumulated at higher levels than the one sorted to the cytosol and chl compartments (Sorrentino et al, 2009). Plants are a cost effective platform for the production high-value recombinant proteins for industrial and clinical applications (Gleba and Giritch, 2014; Makhzoum et al, 2014). Numerous factors have a profound impact in protein accumulation levels among protein

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call